Alembic Pharmaceuticals announces its first product approval from its Formulation Division IV, Jarod Facility
Alembic Pharmaceuticals Ltd has received PAS approval from the US Food & Drug Administration for its sANDA Pregabalin Capsules, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and 300 mg.
Source: equitybulls.com